Ana Isabel Jiménez Millán-rekin lankidetzan egindako argitalpenak (2)

2024

  1. Real-World Evaluation of Once-Weekly Subcutaneous Semaglutide in Patients with Type 2 Diabetes Mellitus in Spain (SEMA-RW Study)

    Nutrients, Vol. 16, Núm. 15

2023

  1. Influence of chronic kidney disease and its severity on the efficacy of semaglutide in type 2 diabetes patients: a multicenter real-world study

    Frontiers in Endocrinology, Vol. 14